Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi's Deal With Medco/UBC Seeks Payer Perspective To Inform Drug R&D, Marketing

This article was originally published in The Pink Sheet Daily

Executive Summary

The multi-year, global data, research and consulting agreement will focus primarily on drugs in Phase II or III.
Advertisement

Related Content

Sanofi/Medco-UBC Evidence Partnership Includes 60 Projects Across Most Therapeutic Categories
Comparative Evidence Needs Earlier Consideration In Drug Development Process – Novartis Exec
Pfizer Seeking Medco’s “Real World Data” For Targeted Therapy Development
Pfizer Research Partnership With Humana Could Inform Drug Development Decisions
Pfizer Research Partnership With Humana Could Inform Drug Development Decisions
New Oncology Indications Should Continue Denosumab’s Upward Trajectory
AstraZeneca, HealthCore Launch Outcomes Data Project, Seek Multi-Stakeholder Consortium
Reenergizing R&D: Sanofi Stirs The Pot, But Does It Have The Recipe?
Reenergizing R&D: Sanofi Stirs The Pot, But Does It Have The Recipe?
Medco "Genetics For Generics" Research Anticipates Plavix Patent Loss

Topics

Advertisement
UsernamePublicRestriction

Register

PS072409

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel